Eracal Therapeutics and Novo Nordisk partner to fight obesity
Novo Nordisk and Eracal Therapeutics of Switzerland have entered into a collaboration to develop and market a molecule program from Eracal, the Swiss company announces in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.